Market Overview
The Global Infusion Pump Market is expected to reach a value of
USD 6.1 billion in 2023, and it is further anticipated to reach a market value of
USD 13.3 billion by 2032 at a
CAGR of 9.0%.
The international infusion pump marketplace encompasses the monetary sports related to the production, distribution, and utilization of infusion pump devices and add-ons worldwide. These medical gadgets, designed for managed and specific fluid delivery into a patient's body, play a crucial position throughout various healthcare settings. The marketplace accommodates diverse types of infusion pumps, consisting of volumetric, insulin, enteral, ambulatory, and implantable pumps, addressing a spectrum of clinical situations. Factors influencing marketplace dynamics encompass technological improvements, the prevalence of persistent illnesses, a developing emphasis on home care, and regulatory trends.
Key Takeaways
- In the context of the product, devices dominate this segment as they hold 63.1% of the market share in 2023.
- Based on application, pediatrics dominates this segment as it holds 28.0% of the market share in 2023.
- Hospitals stand as the predominant end-users in the infusion pump market, driven by their critical patient care infrastructure in 2023.
- North America dominates the global infusion pump market as it holds 51.1% market share in 2023.
Market Dynamic
The infusion pump enterprise is shaped by dynamic factors that affect its demand and supply. Ongoing technological improvements, consisting of smart pumps and more advantageous connectivity, pressure marketplace boom through improving safety and accuracy. The growing occurrence of persistent sicknesses, coupled with a developing old populace, contributes to the demand for infusion pumps, in particular for long-term treatments. Stringent regulatory requirements, healthcare expenditure levels, market consolidation through mergers, and patient options for home-based care additionally affect market dynamics.
Supply chain disruptions, reimbursement guidelines, and the growing consciousness of environmental sustainability similarly form the industry landscape. A successful addition to those dynamic elements is crucial for groups within the infusion pump marketplace to navigate challenges, become aware of possibilities, and continue to be aggressive inside the evolving healthcare environment. Continuous tracking of these marketplace dynamics lets stakeholders alter techniques and innovate in response to emerging trends of this market.
Research Scope and Analysis
By Product
In the context of the product, devices dominate this segment as they hold 63.1% of the market share in 2023 and are expected to show significant growth in the forthcoming period of 2023 to 2032. The dominance of specific products within the infusion pump market is influenced by their efficacy in addressing distinct medical requirements, technological advancements, and adaptability to diverse healthcare settings. Volumetric infusion pumps excel in controlled dosage administration, particularly in critical care scenarios. Insulin pumps lead to diabetes management, providing continuous subcutaneous insulin infusion for better glycemic control. Enteral infusion pumps are essential for nutritional support, while ambulatory pumps offer mobility during infusion therapy.
Implantable pumps cater to long-term therapy needs, such as chronic pain managementIn the accessories and consumables category, dedicated products ensure compatibility, while non-dedicated ones offer versatility across devices. Essential components like infusion catheters and IV administration sets prevent contamination, emphasizing patient safety and maintaining infusion integrity. Overall, the market's evolution is marked by innovations that enhance patient care, user experience, and the range of treatable conditions using infusion pump technology.
By Application
Based on application, pediatrics dominates this phase because it holds 28.0% of the market share in 2023 and is projected to show significant growth in the upcoming length of 2023 to 2032. The dominance of pediatrics within the infusion pump market is rooted in the critical role those gadgets play in addressing the unique healthcare needs of toddlers and youngsters. Infusion pumps are crucial for ensuring unique medicine delivery in pediatric patients, considering their smaller body sizes and wonderful physiological characteristics.
Their versatility allows for the management of medicines, fluids, vitamins, and blood products, making them vital in diverse pediatric care settings, which include neonatal extensive care devices (NICUs) and pediatric oncology devices. In NICUs, infusion pumps contribute significantly to the care of premature and significantly sick infants by way of ensuring accurate shipping of fluids and medicinal drugs. The pumps also play a vital function in dealing with continual situations in pediatrics, including cystic fibrosis and diabetes, wherein non-stop or periodic medicinal drug management is needed.
Additionally, infusion pumps contribute to reducing aches and pain for pediatric sufferers, specifically in instances of repeated or extended medication administration. The developing trend towards domestic healthcare for pediatric sufferers is facilitated through infusion pumps, making an allowance for snug remedy in domestic surroundings under the supervision of healthcare specialists or caregivers. Advancements in pediatric-specific infusion pump designs, featuring adjustable glide charges and person-friendly interfaces, further emphasize the commitment to meeting the specific needs of pediatric populations.
By End User
Hospitals stand as the predominant end-users in the infusion pump market, driven by their critical patient care infrastructure, diverse patient population, and the necessity for precise administration of medications in complex and intensive treatments. The versatility of infusion pumps aligns with the varied medical needs encountered in hospitals, where 24/7 monitoring and support, emergency and trauma care, and inpatient and outpatient services are essential components.
Integrated into healthcare systems, infusion pumps facilitate seamless coordination among specialized departments, such as oncology and neonatal care. Hospitals possess the necessary resources for training healthcare professionals on infusion pump usage, ensuring regulatory compliance, and the safe, effective delivery of care. While home care settings and ambulatory care institutes are growing, the comprehensive capabilities of hospitals in handling diverse medical conditions solidify their continued dominance in the infusion pump market.
The Infusion Pump Market Report is segmented on the basis of the following:
By Product
- Device
- By Product
- Volumetric Infusion Pumps
- Insulin Pumps
- Enteral Infusion Pumps
- Ambulatory Infusion Pumps
- Implantable Infusion Pumps
- By Technology
- Traditional Infusion Pumps
- Specialty Infusion Pumps
- By Type
- Stationary Infusion Pumps
- Portable Infusion Pumps
- Accessories & Consumables
- Dedicated Accessories & Consumables
- Volumetric Infusion pumps
- Insulin Pumps
- Enteral Infusion Pumps
- Syringes Infusion Pumps
- Ambulatory Infusion Pumps
- Implantable Infusion Pumps
- Non-Dedicated Accessories & Consumables
- Infusion Catheters
- IV Administration Sets
- Needleless Connector
- Cannulas
- Tubing & Extension Sets
- Others
By Application
- Pediatrics
- Oncology
- Diabetes Management
- Gastroenterology
- Pain Management
- Hematology
- Others
By End User
- Hospital
- Home Care Settings
- Ambulatory Care Institutes
- Academic & Research Institutes
Regional Analysis
North America dominates the infusion pump marketplace as it
holds 51.1% market proportion in 2023 and is expected to show subsequent growth in the approaching period of 2023 to 2032. This dominance can be attributed to a combination of things. The area advantages from superior healthcare infrastructure, marked by using modern centers and a robust network of healthcare experts. High healthcare expenditure, continually allocating a sizeable part of GDP to healthcare, enables tremendous investments in advanced scientific technologies, such as infusion pumps.
North America's position as a hub for technological advancements and scientific device innovation, together with a stringent regulatory framework ensures product protection and efficacy, in addition, complements its market leadership. The area's expanded incidence of chronic sicknesses and a growing aging population contribute to the sustained need for infusion pumps in various healthcare settings. Market opposition, consolidation via mergers and acquisitions, and a proactive approach to domestic infusion therapy have together bolstered North America's strong presence.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
There are several competitive scenarios in the global infusion pumps market that have given way to key players who drive up growth. Companies like Medtronic plc, Baxter International Inc., and Fresenius Kabi AG among other large corporations have participated in the development of this company. (the acquisition of Hospira), ICU Medical Inc., Johnson & Johnson, and Caesarean Medical Electronics (CME) all contribute significantly to the supply of diverse infusion pump solutions.
Different healthcare systems like hospital-based care and home systems are served by these companies, which also provide custom products in the area of intravenous, epidural internal medicine, or diabetes for market growth factors include mergers and acquisitions new product introductions legislative changes trends that govern these markets.
Some of the prominent players in the Global Infusion Pump Market are:
- Tandem Diabetes Care, Inc.
- Smith Medical
- Terumo Corporation
- Becton, Dickinson and Company
- Fresenius SE & Co. KGaA
- F. Hoffmann-La Roche Ltd.
- B. Braun Holding GmbH & Co. KG
- Baxter International, Inc.
- Medtronic
- ICU Medical, Inc.
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Global Infusion Pump Market:
The global infusion pump marketplace experienced tremendous shifts due to the COVID-19 pandemic and the following financial recession. The accelerated demand for medical equipment pushed through the need to deal with COVID-19 patients, especially in the initial levels of the crisis, placed huge pressure on healthcare facilities, leading to a surge in infusion pump usage.
However, delivery chain disruptions, caused by lockdowns and journey restrictions, hampered the production and distribution of medical devices, doubtlessly resulting in delays. The diversion of resources to control the pandemic and the economic downturn imposed monetary constraints on healthcare spending, influencing purchasing choices and impacting the demand for infusion pumps.
The adoption of telehealth and far-off patient monitoring answers, improved by the pandemic, may additionally have indirectly prompted the management of patients requiring infusion therapy. Additionally, regulatory modifications and expedited approvals through the crisis may have implications for the infusion pump market, with new products getting into the marketplace at an expanded tempo.
Recent Developments
- In September 2023, Fresenius Kabi and Virginia Oncology Associates (VOA) announced a major agreement, with VOA acquiring the Ivenix Infusion System for advanced medication administration in cancer and blood disorder treatments, enhancing therapeutic access.
- In May 2023, Terumo Corporation announced a state-of-the-art manufacturing facility in Yamanashi, Japan dedicated to infusion pump manufacturing.
- In September 2023, Terumo Blood and Cell Technologies released a groundbreaking protocol for the automated expansion of HEK293T cells, crucial for viral vector production in cell and gene therapies.
- In December 2022, Medtronic's Extended Infusion Set entered an exclusive partnership with Convatec Group for subcutaneous insulin infusion, aiding diabetes management.
- In August 2022, Baxter International Inc., renowned for pioneering technology in medication delivery, secured clearance from the United States Food and Drug Administration (FDA) through the 510(k) pathway for its cutting-edge Novum IQ Syringe Infusion Pump (SYR) equipped with the advanced Dose IQ Safety Software.
Report Details
| Report Characteristics |
| Market Size (2023) |
USD 6.1 Bn |
| Forecast Value (2032) |
USD 13.3 Bn |
| CAGR (2023-2032) |
9.0% |
| Historical Data |
2018 – 2023 |
| Forecast Data |
2024 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product (Device and Accessories &
Consumables), By Application (Pediatrics, Oncology,
Diabetes Management, Gastroenterology, Pain
Management, Hematology, and Others), By End User
(Hospital, Home Care Settings, Ambulatory Care
Institutes and Academic & Research Institutes) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Tandem Diabetes Care Inc., Smith Medical, Terumo
Corporation, Becton Dickinson and Company,
Fresenius SE & Co. KGaA, F. Hoffmann-La Roche Ltd.,
B. Braun Holding GmbH & Co. KG, Baxter
International Inc., Medtronic, ICU Medical, Inc., and
Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Infusion Pump Market size is estimated to have a value of USD 6.1 billion in 2023 and is expected to reach USD 13.3 billion by the end of 2032.
North America has the largest market share for the Global Infusion Pump Market with a share of about 51.1% in 2023.
Some of the major key players in the Global Infusion Pump Market are Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, and many others.
The market is growing at a CAGR of 9.0 percent over the forecasted period.